Effects of prolactin on movement disorders and APOE, GFAP, and PRL receptor gene expression following intracerebral hemorrhage in rats

Intracerebral hemorrhage (ICH) occurs mostly in the striatum. In ICH, blood prolactin level increases 3-fold. The effects of intracerebroventricular injection (ICV) of prolactin on motor disorders will be investigated. This study was performed on 32 male Wistar rats in 4 groups: sham, ICH, and prolactin with 1 μg/2 μl (P1) and 2 μg/2 μl (P2) doses. The weight of animals on days 1 ( ˂0.01), 3, and 7 ( ˂0.05) in the sham and P2 groups increased compared with the ICH group. Neurological Deficit Score (NDS) in ICH and P1 groups decreased, and increased compared with sham and ICH groups ( ˂0.001), respectively. NDS in the P1 group increased compared with the P2 group on days 1 ( ˂0.0 5), 3, and 7 ( ˂0.001). The duration time of rotarod in ICH and P1 groups decreased and increased compared with sham and ICH groups ( ˂0.001), respectively. The duration time of rotarod in the P1 group on days 3 and 7 increased compared with the P2 group ( ˂0.001). Travel distance in days 1( ˂0.01), 3( ˂0.001), and 7( ˂0.01) decreased in the ICH group. Prolactin receptor (PRL receptor) expression in ICH, P1, and P2 groups increased compared with sham and ICH groups ( ˂0.001). Glial fibrillary acidic protein (GFAP) expression ( ˂0.001) and apolipoprotein E (APOE) ( ˂0.01) expression in the ICH group increased compared with the sham group. GFAP and APOE expression in the P1 group increased compared with the ICH group ( ˂0.001). APOE expression in the P1 group increased compared with the P2 group ( ˂0.001). According to the results, prolactin reduces movement disorders.